J&J reports quarterly loss on $13.6 billion tax charge

(Reuters) - Johnson & Johnson reported a quarterly loss due to a $13.6 billion charge related to the new U.S. tax law, but beat adjusted quarterly profit estimate on strong demand for new cancer drugs and gains from its Actelion acquisition.

J&J reports quarterly loss on $13.6 billion tax charge
Read More


Bagikan Berita Ini